Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-66311.93%
operating margin TTM
-75653.98%
revenue TTM
661.24 Thousand
revenue per share TTM
0.02$
valuation ratios | |
|---|---|
| pe ratio | -28.11 |
| peg ratio | -0.28 |
| price to book ratio | 9.72 |
| price to sales ratio | 19,264.95 |
| enterprise value multiple | -25.90 |
| price fair value | 9.72 |
profitability ratios | |
|---|---|
| gross profit margin | -160.09% |
| operating profit margin | -75653.98% |
| pretax profit margin | -66209.48% |
| net profit margin | -66311.93% |
| return on assets | -32.46% |
| return on equity | -36.44% |
| return on capital employed | -39.02% |
liquidity ratios | |
|---|---|
| current ratio | 19.31 |
| quick ratio | 18.82 |
| cash ratio | 2.73 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 7,044.86 |
| operating cycle | 9,779.57 |
| days of payables outstanding | 1,455.49 |
| cash conversion cycle | 8,324.08 |
| receivables turnover | 0.13 |
| payables turnover | 0.25 |
| inventory turnover | 0.05 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.01 |
| total debt to capitalization | 0.01 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -23.12 |
cash flow ratios | |
|---|---|
| free cash flow per share | -10.52 |
| cash per share | 34.17 |
| operating cash flow per share | -10.44 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -23.12 |
| short term coverage ratios | -135.71 |
| capital expenditure coverage ratio | -132.27 |
Frequently Asked Questions
When was the last time Karuna Therapeutics, Inc. (NASDAQ:KRTX) reported earnings?
Karuna Therapeutics, Inc. (KRTX) published its most recent earnings results on 22-02-2024.
What is Karuna Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Karuna Therapeutics, Inc. (NASDAQ:KRTX)'s trailing twelve months ROE is -36.44%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Karuna Therapeutics, Inc. (KRTX) currently has a ROA of -32.46%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did KRTX's net profit margin stand at?
KRTX reported a profit margin of -66311.93% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is KRTX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 19.31 in the most recent quarter. The quick ratio stood at 18.82, with a Debt/Eq ratio of 0.01.